
The Moore Family Trust Foundation has long been recognized for its steadfast support of transformational medical research, innovative treatment, and collaboration with leading research institutions throughout the world.
We have shared in the achievements of our partners when advances have changed lives and improved outcomes, and we have remained equally committed when research has required perseverance, reassessment, and continued investment.
We are humbled and honored to have participated in efforts that have helped shape the future of medicine while bringing hope, possibility, and improved care to patients and their families.
Effective October 1, 2026, the Foundation will continue to support significant initiatives focused on medical research, treatment advancement, and measurable patient outcomes.
Following extensive discussion, the Board of Directors and our Chairman have adopted a policy of greater institutional discretion regarding the Foundation’s philanthropic activities. Accordingly, public announcements concerning transformational gifts, donor-advised funds, institutional giving strategies, and related philanthropic commitments will generally cease.
This decision reflects several considerations, foremost among them a commitment to discretion within the philanthropic and institutional communities in which we serve.
Our engagement will continue undiminished, as will the purpose and conviction from which it has always stemmed. Going forward, these activities will remain private unless circumstances, institutional considerations, or the nature of a particular initiative warrant public acknowledgment.
The work continues. Its purpose remains unchanged. Its visibility will simply be more measured.

Abby Aaronson
Chief Legal Officer
Moore Family Trust Foundation

Lisa Hubert
General Counsel
MCH; MFTF; MLD
Boston, Massachusetts
617-214-4733

Jeffrey Minton
Chief Financial Officer
MCH; MFTF, MLD
Boston, Massachusetts
617-214-4733
Moore Family Trust Foundation
Boston, M